- Home
- VIR vs ACP Comparison
VIR vs ACP Comparison
Compare VIR & ACP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- ACP
- Stock Information
- Founded
- VIR 2016
- ACP 2010
- Country
- VIR United States
- ACP United States
- Employees
- VIR N/A
- ACP N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- ACP Investment Managers
- Sector
- VIR Health Care
- ACP Finance
- Exchange
- VIR Nasdaq
- ACP Nasdaq
- Market Cap
- VIR 724.1M
- ACP 677.5M
- IPO Year
- VIR 2019
- ACP N/A
- Fundamental
- Price
- VIR $5.57
- ACP $5.47
- Analyst Decision
- VIR Buy
- ACP
- Analyst Count
- VIR 6
- ACP 0
- Target Price
- VIR $35.67
- ACP N/A
- AVG Volume (30 Days)
- VIR 1.4M
- ACP 337.9K
- Earning Date
- VIR 05-01-2025
- ACP 01-01-0001
- Dividend Yield
- VIR N/A
- ACP 17.79%
- EPS Growth
- VIR N/A
- ACP N/A
- EPS
- VIR N/A
- ACP N/A
- Revenue
- VIR $74,205,000.00
- ACP N/A
- Revenue This Year
- VIR N/A
- ACP N/A
- Revenue Next Year
- VIR $17.69
- ACP N/A
- P/E Ratio
- VIR N/A
- ACP N/A
- Revenue Growth
- VIR N/A
- ACP N/A
- 52 Week Low
- VIR $4.95
- ACP $5.55
- 52 Week High
- VIR $14.45
- ACP $7.17
- Technical
- Relative Strength Index (RSI)
- VIR 35.32
- ACP 39.30
- Support Level
- VIR $4.95
- ACP $5.33
- Resistance Level
- VIR $6.02
- ACP $5.65
- Average True Range (ATR)
- VIR 0.48
- ACP 0.16
- MACD
- VIR -0.00
- ACP -0.03
- Stochastic Oscillator
- VIR 29.25
- ACP 51.89
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.